Company profile: Cord:Use
1.1 - Company Overview
Company description
- Provider of cord blood and tissue banking services, preserving umbilical cord stem cells used in treating nearly 80 diseases, and public cord blood donation to build an inventory for patients needing transplants. Offers planned infusion clinics administering cellular therapies under FDA-approved INDs, conducts R&D on treatments for autism and cerebral palsy, and delivers virtual educational seminars.
Products and services
- Public Cord Blood Banking: Delivers a transplant-focused program allowing donation of umbilical cord blood units, constructing an accessible inventory used by patients in need and already supporting over 600 transplantations
- Cord Blood Banking: Produces a therapeutic-use preservation service for umbilical cord blood stem cell units, maintaining viable cells leveraged in the treatment of nearly 80 diseases for transplant needs
- Cord Tissue Banking: Supplies a multipotent-stem-cell preservation service archiving umbilical cord tissue that contains stem cells able to differentiate into various cell types
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cord:Use
Kendall Research Systems
HQ: United States
Website
- Description: Provider of pioneering novel tools for neuroscience discovery using optogenetic techniques, operating as an R&D think tank developing technologies in bioinstrumentation, ultra-low power computation, and communications links; originated in 2011 as an optical neural interface technology spin-out from MIT's Synthetic Neurobiology Lab.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kendall Research Systems company profile →
Applied StemCell
HQ: United States
Website
- Description: Provider of animal and cell line models as tools for drug discovery and diagnostics, leveraging proprietary TARGATT gene modification technology to create site-specific knock-in mouse, rat, and human cell line models quickly and efficiently for the pharmaceutical and academic community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied StemCell company profile →
Enlight Biosciences
HQ: United States
Website
- Description: Provider of technology platforms and software, including Entrega for enabling oral delivery of complex biological molecules and drug substances, KNODE for connecting users with experts and their content within and beyond R&D organizations, and Peerin, a Twitter application that helps professionals discover industry-specific insights by identifying and ranking high-value conversations and trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enlight Biosciences company profile →
Dynamic Biosensors
HQ: Germany
Website
- Description: Provider of a platform and analysis system for molecular interaction analysis to identify pharmaceutical substances.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dynamic Biosensors company profile →
Accel Biotech
HQ: United States
Website
- Description: Provider of OEM robotic engines, liquid handling solutions, customized robotics, and components, manufacturing and distributing these offerings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accel Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cord:Use
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cord:Use
2.2 - Growth funds investing in similar companies to Cord:Use
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cord:Use
4.2 - Public trading comparable groups for Cord:Use
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →